Drug interactions
Siponimod + Tumor necrosis factor-alpha adenovector
Severity: Moderate
Siponimod and Tumor necrosis factor-alpha adenovector: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Siponimod reduces lymphocyte circulation, while an adenoviral vector product is a replication-deficient viral agent that may be handled less effectively by an immunosuppressed host. The combination could increase infection risk, although data are minimal.
What this interaction means in plain words
Siponimod and Tumor necrosis factor-alpha adenovector can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive immunosuppression predicted from siponimod's lymphocyte sequestration; no direct interaction data exist.
What to do
Monitor for infection and check lymphocyte counts during combined use. Review the vector product labeling for guidance on immunosuppressed patients.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Siponimod and Tumor necrosis factor-alpha adenovector, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Siponimod
- Cladribine + Siponimod Contraindicated
- Fingolimod + Siponimod Contraindicated
- Fluconazole + Siponimod Contraindicated
- Influenza virus vaccine quadrivalent intranasal + Siponimod Contraindicated
- Ponesimod + Siponimod Contraindicated
- Siponimod + Thioridazine Contraindicated
Frequently asked questions
Can I take Siponimod with Tumor necrosis factor-alpha adenovector?
MediHelp rates the interaction as moderate. Siponimod and Tumor necrosis factor-alpha adenovector can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Siponimod reduces lymphocyte circulation, while an adenoviral vector product is a replication-deficient viral agent that may be handled less effectively by an immunosuppressed host. The combination could increase infection risk, although data are minimal.
How serious is the interaction between Siponimod and Tumor necrosis factor-alpha adenovector?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for infection and check lymphocyte counts during combined use. Review the vector product labeling for guidance on immunosuppressed patients.
What other medicines interact with Siponimod?
MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
